X0206 3 2019-03-27 0 0001357874 PRECISION BIOSCIENCES INC DTIL 0001397607 Schinazi Raymond F C/O PRECISION BIOSCIENCES, INC. 302 E. PETTIGREW STREET, SUITE A-100 DURHAM NC 27701 1 0 0 0 Series B Preferred Stock Common Stock 56102 I By RFS Partners, LP Each share of Series B Preferred Stock is convertible at the holder's election into approximately 0.468452971537734 share of the common stock of Precision BioSciences, Inc. (the "Issuer") (on an adjusted basis, after giving effect to the 1-for-2.134686 reverse stock split effected by the Issuer in connection with its initial public offering) and has no expiration date. The Series B Preferred Stock will automatically convert into common stock upon the closing of the Issuer's initial public offering. The securities reported herein are held of record by RFS Partners, LP ("RFS"). RFS & Associates, LLC ("RFS & Associates") is the general partner of RFS, and the reporting person is a limited partner of RFS as well as the manager of RFS & Associates. The reporting person disclaims beneficial ownership of the securities held by RFS, except to the extent of any pecuniary interest therein. Exhibit List: Exhibit 24 - Power of Attorney /s/ Abid Ansari, Attorney-in-Fact for Raymond F. Schinazi 2019-03-27